Integrin α10β1-selected mesenchymal stem cells reduced hypercoagulopathy in a porcine model of acute respiratory distress syndrome

Abstract Mesenchymal stem cells (MSCs) have been studied for their potential benefits in treating acute respiratory distress syndrome (ARDS) and have reported mild effects when trialed within human clinical trials. MSCs have been investigated in preclinical models with efficacy when administered at...

Полное описание

Библиографические подробности

Главные авторы:	Dag Edström, Anna Niroomand, Martin Stenlo, Kristina Uvebrant, Deniz A. Bölükbas, Gabriel Hirdman, Ellen Broberg, Hooi Ching Lim, Snejana Hyllén, Evy Lundgren-Åkerlund, Leif Pierre, Franziska Olm, Sandra Lindstedt
Формат:	Artigo
Язык:	Inglês
Опубликовано:	BMC 2023-05-01
Серии:	Respiratory Research
Предметы:	Acute respiratory distress syndrome Integrin α10β1 mesenchymal stem cells Lung disease Advanced therapeutic medicinal products
Online-ссылка:	https://doi.org/10.1186/s12931-023-02459-6
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!